Cardiovascular Research

Coronary artery calcium testing: A call for universal coverage.

Authors: Morteza Naghavi|||David J Maron|||Robert A Kloner|||David S Berman|||Mathew Budoff|||H Robert Superko|||P K Shah

Affiliations: + Expand

Abstract

Heart attacks kill more Americans than all cancers combined. Fatal heart attack victims have no symptoms until minutes before they die, hence early detection of high-risk asymptomatic individuals is needed. Even though heart attacks kill and cost more than cancers, as a nation we spend over 20 times more on screening for asymptomatic cancer than for asymptomatic atherosclerotic cardiovascular disease (ASCVD), the underlying cause of heart attacks. Currently, payers only cover screening for risk factors of ASCVD such as blood pressure and blood cholesterol. This approach tends to miss high-risk and over-treat low-risk individuals. Although treadmill stress testing with ECG is not indicated for ASCVD detection in asymptomatic individuals, it is done often, and frequently leads to misleading conclusions or unnecessary downstream diagnostic procedures. For example, former President Clinton had passed his treadmill stress tests for several years during his presidential annual checkup but had a heart attack shortly after his presidency. This common practice is a waste of our limited resources. Instead, a more accurate risk assessment using coronary artery calcium (CAC) testing is available; and has just been adopted by ACC/AHA guidelines, however payers do not cover it. CAC is measured non-invasively with a 5-minute CT-scan of the heart, and costs less than $200, whereas cancer screening with colonoscopy and mammography costs over $3000. There is an opportunity to save lives and dollars if CAC testing is covered for appropriately selected individuals. Texas has already passed HB1290 to mandate CAC coverage. Other states must step up and take actions.

---

Reference List

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146-e603. Epub 2017/01/27. doi:10.1161/CIR.0000000000000485. PubMed PMID: 28122885; PubMed Central PMCID: PMCPMC5408160.|||Blaha MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, Blankstein R, Budoff MJ, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133(9):849–58. Epub 2016/01/24. doi:10.1161/CIRCULATIONAHA.115.018524. PubMed PMID: 26801055; PubMed Central PMCID: PMCPMC4775391.|||Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49(18):1860–70. Epub 2007/05/08. doi:10.1016/j.jacc.2006.10.079. PubMed PMID: 17481445.|||Burgstahler C, Cipowicz H, Thomas C, Schabel C, Mangold S, Ketelsen D, et al. Coronary and carotid atherosclerosis in asymptomatic male marathon runners. Scand J Med Sci Sports. 2017. Epub 2017/12/15. doi:10.1111/sms.13035. PubMed PMID: 29239051.|||Casper M, Kramer MR, Quick H, Schieb LJ, Vaughan AS, Greer S. Changes in the geographic patterns of heart disease mortality in the United States: 1973 to 2010. Circulation. 2016;133(12):1171–80. Epub 2016/03/24. doi:10.1161/CIRCULATIONAHA.115.018663. PubMed PMID: 27002081; PubMed Central PMCID: PMCPMC4836838.|||Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347(9013):1447–51. Epub 1996/05/25. PubMed PMID: 8676628.|||Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation. 1990;82(3 Suppl):II38–46. Epub 1990/09/01. PubMed PMID: (2203563).|||Dawber TR, Kannel WB, Revotskie N, Stokes J, 3rd, Kagan A, Gordon T. Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health Nations Health. 1959;49:1349–56. Epub 1959/10/01. PubMed PMID: 13814552; PubMed Central PMCID: PMCPMC1372949.|||Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am. J. Cardiol. 1989;63(10):114E-20E. Epub 1989/03/07. PubMed PMID: (2646888).|||Fuster V, Steele PM, Chesebro JH. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J. Am. Coll. Cardiol. 1985;5(6 Suppl):175B-84B. Epub 1985/06/01. PubMed PMID: (3889109).|||Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49–73. Epub 2013/11/14. doi:10.1161/01.cir.0000437741.48606.98. PubMed PMID: 24222018.|||Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49(3):378–402. Epub 2007/01/24. doi:10.1016/j.jacc.2006.10.001. PubMed PMID: 17239724.|||Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J. Am. Coll. Cardiol. 2018;72(4):434–47. Epub 2018/07/22. doi:10.1016/j.jacc.2018.05.027. PubMed PMID: (30025580).|||Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. J Am Coll Cardiol. 2018 Nov 8.|||H. 4839, (2017–2018).|||HB1290, (2006)|||Hecht HS, Henschke C, Yankelevitz D, Fuster V, Narula J. Combined detection of coronary artery disease and lung cancer. Eur. Heart J. 2014;35(40):2792–6. Epub 2014/08/13. doi:10.1093/eurheartj/ehu296. PubMed PMID: (25112665).|||Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44. Epub 2011/01/26. doi:10.1161/CIR.0b013e31820a55f5. PubMed PMID: 21262990.|||Maron DJ. Preventive interventions after coronary artery calcium scanning: seeing is believing. JACC Cardiovasc. Imaging 2017;10(8):843–4. Epub 2017/08/12. doi:10.1016/j.jcmg.2017.02.025. PubMed PMID: (28797403).|||Min JK, Lin FY, Gidseg DS, Weinsaft JW, Berman DS, Shaw LJ, et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? J Am Coll Cardiol. 2010;55(11):1110–7. Epub 2010/03/13. doi:10.1016/j.jacc.2009.08.088. PubMed PMID: 20223365.|||Naghavi M. Asymptomatic atherosclerosis: pathophysiology, detection, and treatment. New York: Humana Press; 2010. xxii, 737 p. p.|||Naghavi M. The First Heart Attack Preventive Screening Bill Becomes Law in Texas www.shapesociety.org2015. Available from: http://shapesociety.org/the-first-heart-attack-preventive-screening-bill-becomes-law-in-texas/.|||Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003a;108(14):1664–72. Epub 2003/10/08. doi:10.1161/01.CIR.0000087480.94275.97. PubMed PMID: 14530185.|||Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003b;108(15):1772–8. Epub 2003/10/15. doi:10.1161/01.CIR.0000087481.55887.C9. PubMed PMID: 14557340.|||Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98(2A):2H-15H. Epub 2006/07/18. doi:10.1016/j.amjcard.2006.03.002. PubMed PMID: 16843744.|||Pletcher M. When is measuring a coronary artery calcium score cost effective? Am. Coll. Cardiol. June 14, 2016 https://www.acc.org/latest-in-cardiology/articles/2016/06/14/09/17/when-is-measuring-a-coronary-artery-calcium-score-cost-effective.|||Rankings AsH. Texas; United States: 2016. Trend: Heart Disease.https://www.americashealthrankings.org/explore/2016-annual-report/measure/CHD/state/TX Available from:|||Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57(15):1622–32. Epub 2011/03/29. doi:10.1016/j.jacc.2011.01.019. PubMed PMID: 21439754; PubMed Central PMCID: PMCPMC3104928.|||Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Jr., Dai D, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009;157(1):111–7 e2. Epub 2008/12/17. doi:10.1016/j.ahj.2008.08.010. PubMed PMID: 19081406.|||Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffmann U, Cury RC, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging. 2009;2(6):675–88. Epub 2009/06/13. doi:10.1016/j.jcmg.2008.12.031. PubMed PMID: 19520336.|||Schurgers LJ, Akbulut AC, Kaczor DM, Halder M, Koenen RR, Kramann R. Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles. Front Cardiovasc Med. 2018;5:36. Epub 2018/04/24. doi:10.3389/fcvm.2018.00036. PubMed PMID: 29682509; PubMed Central PMCID: PMCPMC5897433.|||Shaw L.J., Blankstein R. Humana Press; New York: 2010. Asymptomatic Atherosclerosis: Pathophysiology, Detection, and Treatment. (737 p)|||Shaw LJ, Goyal A, Mehta C, Xie J, Phillips L, Kelkar A, et al. 10-year resource utilization and costs for cardiovascular care. J Am Coll Cardiol. 2018;71(10):1078–89. Epub 2018/03/10. doi:10.1016/j.jacc.2017.12.064. PubMed PMID: 29519347; PubMed Central PMCID: PMCPMC5846485.|||Valenti V, B OH, Heo R, Cho I, Schulman-Marcus J, Gransar H, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging. 2015;8(8):900–9. Epub 2015/07/21. doi:10.1016/j.jcmg.2015.01.025. PubMed PMID: 26189116; PubMed Central PMCID: PMCPMC4537357.|||Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–360. Epub 2015/12/18. doi:10.1161/CIR.0000000000000350. PubMed PMID: 26673558.|||Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308(8):788–95. Epub 2012/08/23. doi:10.1001/jama.2012.9624. PubMed PMID: 22910756; PubMed Central PMCID: PMCPMC4141475.